Ramasastry Saira — SEC insider filings

SEC reporting owner CIK 1547959. 40 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 40 filings on record, filed 2020-10-13 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Mirum Pharmaceuticals, Inc. (MIRM)Director16—14 legs · 53,180 sh · $2,608,38334
Vir Biotechnology, Inc. (VIR)Director10—5 legs · 24,187 sh · $761,09415
SANGAMO THERAPEUTICS, INC (SGMO)Director3—1 leg · 10,000 sh · $132,7476
Day One Biopharmaceuticals, Inc. (DAWN)Director7—1 leg · 10,000 sh · $131,87723
Akouos, Inc. (AKUS)Director3——3
Sensei Biotherapeutics, Inc. (FTH)Director1——1

Insider filings — Ramasastry Saira

FiledFormIssuerReported transactionsSource
2026-11-174Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,000 @ $28.97 · Sale (S): 2,000 @ $92.28 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2026-06-174Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 3,772 (derivative) @ $0 · Grant/award (A): 1,980 (derivative) @ $0EDGAR
2026-06-164Sensei Biotherapeutics, Inc. (FTH)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2026-06-024Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 3,977 · Sale (S): 3,977 @ $100 · Option exercise (M): 3,977 (derivative) @ $0EDGAR
2026-05-184Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $109.47 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2026-04-234Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 40,485 · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 47,581 (derivative) · Disposition to issuer (D): 28,700 (derivative) · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 32,335 (derivative) · +2 moreEDGAR
2026-04-164Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $96.90 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2026-03-174Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $90.76 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2026-02-174Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $102.09 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2026-01-164Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,000 @ $23.51 · Sale (S): 2,000 @ $90.99 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2025-12-234Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 5,000 @ $23.51 · Sale (S): 5,000 @ $80 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2025-12-194Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 2,000 @ $23.51 · Sale (S): 1,000 @ $69.46 · Sale (S): 1,000 @ $70 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2025-11-074Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 40,000 (derivative) @ $0 · Grant/award (A): 40,000 (derivative) @ $0 · Disposition to issuer (D): 47,581 (derivative) @ $0 · Grant/award (A): 47,581 (derivative) @ $0 · Disposition to issuer (D): 28,700 (derivative) @ $0 · Grant/award (A): 28,700 (derivative) @ $0 · +4 moreEDGAR
2025-09-104Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 17,000 @ $23.51 · Sale (S): 17,000 · Option exercise (M): 17,000 (derivative) @ $0EDGAR
2025-06-044Mirum Pharmaceuticals, Inc. (MIRM)Sale (S): 5,703 @ $46.20 · Option exercise (M): 2,500 @ $14.12 · Sale (S): 2,500 @ $45.74 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2025-06-044Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-024Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 5,703 · Option exercise (M): 5,703 (derivative) @ $0 · Grant/award (A): 6,268 (derivative) @ $0 · Grant/award (A): 3,977 (derivative) @ $0EDGAR
2025-06-024Vir Biotechnology, Inc. (VIR)Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2024-06-214Day One Biopharmaceuticals, Inc. (DAWN)Sale (S): 10,000 @ $13.19EDGAR
2024-06-124Vir Biotechnology, Inc. (VIR)Sale (S): 4,000 @ $10.95EDGAR
2024-06-074Mirum Pharmaceuticals, Inc. (MIRM)Option exercise (M): 5,000 @ $14.12 · Sale (S): 5,000 @ $25.68 · Option exercise (M): 5,000 (derivative) @ $0 · Grant/award (A): 8,779 (derivative) @ $0 · Grant/award (A): 5,703 (derivative) @ $0EDGAR
2024-06-034Vir Biotechnology, Inc. (VIR)Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0EDGAR
2024-05-284Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 32,335 (derivative) @ $0EDGAR
2023-06-264Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 37,500 (derivative) @ $0EDGAR
2023-06-144Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2023-06-024Vir Biotechnology, Inc. (VIR)Sale (S): 3,500 @ $25.67EDGAR
2023-05-244Vir Biotechnology, Inc. (VIR)Grant/award (A): 6,027 @ $0 · Grant/award (A): 12,054 (derivative) @ $0EDGAR
2022-12-024Akouos, Inc. (AKUS)Disposition to issuer (D): 16,000 (derivative)EDGAR
2022-07-134Vir Biotechnology, Inc. (VIR)Grant/award (A): 5,000 @ $12.76 · Sale (S): 5,000 @ $30 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2022-06-274Akouos, Inc. (AKUS)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2022-06-234Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 28,700 (derivative) @ $0EDGAR
2022-06-064Mirum Pharmaceuticals, Inc. (MIRM)Grant/award (A): 34,000 (derivative) @ $0EDGAR
2022-05-254Vir Biotechnology, Inc. (VIR)Grant/award (A): 6,405 @ $0 · Sale (S): 1,687 @ $23.82 · Grant/award (A): 12,810 (derivative) @ $0EDGAR
2022-03-014SANGAMO THERAPEUTICS, INC (SGMO)Grant/award (A): 12,500 @ $0 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2021-06-254Akouos, Inc. (AKUS)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2021-05-254Vir Biotechnology, Inc. (VIR)Grant/award (A): 3,374 @ $0 · Grant/award (A): 6,748 (derivative) @ $0EDGAR
2021-05-204Vir Biotechnology, Inc. (VIR)Option exercise (M): 10,000 @ $12.76 · Sale (S): 10,000 @ $43.73 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-03-014SANGAMO THERAPEUTICS, INC (SGMO)Grant/award (A): 8,200 @ $0 · Grant/award (A): 16,400 (derivative) @ $0EDGAR
2020-12-184SANGAMO THERAPEUTICS, INC (SGMO)Option exercise (M): 10,000 @ $5.99 · Sale (S): 10,000 @ $13.27 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2020-10-134/AVir Biotechnology, Inc. (VIR)Grant/award (A): 24,497 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1547959 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs